psoriasis: An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
518 |
4. Check minimum number of eventsNone |
518 |
5. Include endpointsNone |
518 |
6. Filter based on genotype QC (FinnGen only) |
518 |
Control definitions (FinnGen only)
- Control exclude
- L12_PAPULOSQUAMOUS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L40
- Name in latin
- Psoriasis guttata
Similar endpoints
↥List of similar endpoints to
Guttate psoriasis
based on the number of shared cases.
Similar with more cases:
- Psoriasis
- Papulosquamous disorders
- Autoimmune diseases related-to ILD
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3699 | 2116 | 1568 |
| Only index persons | 3553 | 2064 | 1489 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.06 | 0.04 |
| Only index persons | 0.07 | 0.08 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 41.77 | 41.62 | 41.86 |
| Only index persons | 41.40 | 41.48 | 41.29 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 518 | 320 | 198 |
| Unadjusted period prevalence (%) | 0.10 | 0.11 | 0.09 |
| Median age at first event (years) | 46.58 | 44.06 | 50.65 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 466
- Matched controls
- 4658
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D05AX52
ATC
calcipotriol, combinations; topical
195.0
323.0
321
52
L40.4
ICD-10 Finland
Guttate psoriasis
4503599627370496.0
323.0
460
*
L40.0
ICD-10 Finland
Psoriasis vulgaris
1243.5
323.0
331
9
D05AX02
ATC
calcipotriol; topical
137.0
230.1
234
34
D07XC01
ATC
betamethasone, combinations; topical
24.7
168.9
263
232
D07AC01
ATC
betamethasone; topical
13.2
133.6
364
989
D05BB02
ATC
acitretin; oral
108.8
125.3
133
17
E0000UV
ATC
NA
12.0
119.6
380
1251
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
+∞
111.0
102
*
D05AX03
ATC
calcitriol; topical
140.1
104.2
108
10
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
15.9
99.4
175
170
E000001
ATC
NA
8.8
94.2
258
574
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
95.1
84.8
92
12
L40.5
ICD-10 Finland
Arthropathic psoriasis
960.6
84.3
80
*
L40.9
ICD-10 Finland
Psoriasis, unspecified
152.3
84.2
87
7
D07AC13
ATC
mometasone; topical
7.2
83.6
284
826
D07AD01
ATC
clobetasol; topical
8.9
81.0
203
371
L40
ICD-10 Finland
Psoriasis
96.6
80.3
87
11
D07AB08
ATC
desonide; topical
9.0
65.8
156
247
D07AB02
ATC
hydrocortisone butyrate; topical
5.8
65.5
262
850
M07.3
ICD-10 Finland
Other psoriatic arthropathies
606.4
55.8
54
*
E000002
ATC
NA
7.5
54.3
144
262
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
+∞
47.7
45
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
8.2
45.8
111
172
TQW80
NOMESCO Finland
Local dermatologic skincare
21.0
42.8
64
35
E000003
ATC
NA
10.5
42.5
87
100
D02AE01
ATC
carbamide; topical
9.0
42.3
95
129
S91
ICPC
Psoriasis
69.2
38.8
44
7
D02AX
ATC
Other emollients and protectives
11.9
32.6
61
58
D05AA
ATC
Tars
94.5
32.2
35
*
E000007
ATC
NA
7.8
31.6
76
113
L40.8
ICD-10 Finland
Other psoriasis
118.1
31.1
33
*
134
Kela drug reimbursment
General erythroderma
322.3
30.2
30
*
L04AB04
ATC
adalimumab; parenteral
23.5
28.8
41
19
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
10.8
28.6
56
58
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
5.1
27.5
94
219
69619
ICD-8 Finland
Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)
+∞
24.2
23
*
6961A
ICD-9 Finland
Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]
+∞
21.0
20
*
L04AC05
ATC
ustekinumab; parenteral
219.4
20.7
21
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
5.6
20.5
62
124
XQ848
NOMESCO Finland
Dermatological photography
12.6
19.1
34
29
E000006
ATC
NA
4.9
19.0
65
149
L04AC10
ATC
secukinumab; parenteral
+∞
17.8
17
*
M07.0*L40.5
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
+∞
16.8
16
*
D07AA02
ATC
hydrocortisone; topical
3.1
15.1
92
345
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.8
15.0
108
451
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.5
14.5
134
644
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
9.6
14.4
29
32
D07XB01
ATC
flumetasone, combinations; topical
29.3
13.0
17
6
H02AB06
ATC
prednisolone; systemic
2.1
12.6
229
1485
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
8.0
12.6
28
37
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
13.9
12.0
20
15
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.9
11.9
50
140
A07EC01
ATC
sulfasalazine; oral, rectal
3.6
11.9
54
162
D09AB01
ATC
zinc bandage without supplements; topical
8.5
11.7
25
31
L04AD01
ATC
ciclosporin; systemic
8.7
11.4
24
29
L04AB01
ATC
etanercept; parenteral
13.1
11.2
19
15
J01FF01
ATC
clindamycin; systemic
2.2
11.2
143
790
6960A
ICD-9 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
+∞
10.5
10
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.3
10.2
52
171
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
10.2
190
1216
L04AA01
ATC
[U] ciclosporin; systemic
9.4
10.1
20
22
L04AC16
ATC
guselkumab; systemic
+∞
9.4
9
*
377
Kela drug reimbursment
Apremilast and dimethyl fumarate (psoriasis)
+∞
9.4
9
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.9
8.9
55
206
WQ066
NOMESCO Finland
NA
91.7
8.4
9
*
L04AC18
ATC
risankizumab; parenteral
+∞
8.4
8
*
L04AC13
ATC
ixekizumab; parenteral
+∞
8.4
8
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
7.8
199
1384
RJ411
NOMESCO Finland
NA
15.3
7.7
12
8
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.2
7.7
40
134
A46
ICD-10 Finland
Erysipelas
2.4
7.4
65
297
Z71.8
ICD-10 Finland
Other specified counselling
1.9
7.4
120
714
M54.5
ICD-10 Finland
Low back pain
1.8
7.3
156
1020
M07.2*L40.5
ICD-10 Finland
Psoriatic spondylitis
+∞
7.3
7
*
D05AX05
ATC
tazarotene; topical
+∞
7.3
7
*
M07.0
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
+∞
7.3
7
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
7.5
7.2
16
22
SPAT1263
SPAT
Sampling
1.7
7.2
200
1415
RJ421
NOMESCO Finland
NA
20.4
7.2
10
5
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
6.9
48
195
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
6.6
64
308
S18
ICPC
Laceration/cut
1.7
6.5
177
1236
L04AA32
ATC
apremilast; oral
+∞
6.3
6
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
6.1
214
1592
J01DB01
ATC
cefalexin; oral
1.8
6.1
380
3310
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.0
6.1
86
482
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
27
14
20.29
34.67
2.0
1.1
ug/l
7.5
10.0
1.31
27
14
(42870588) Differential panel, method unspecified - Blood
256
1328
2.83
29.72
10.6
5.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
340
2068
2.87
28.63
12.2
5.2
e9/l
0.6
0.6
1.63
317
1805
(3006315) Basophils [#/volume] in Blood
341
2080
2.87
28.51
12.3
5.3
e9/l
0.0
0.0
1.62
317
1816
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
58
117
5.46
27.94
1.5
1.6
iu/ml
1.0
0.0
—
10
21
(3013115) Eosinophils [#/volume] in Blood
347
2167
2.82
27.16
12.3
5.5
e9/l
0.2
0.2
0.37
326
1923
(3022096) Basophils/100 leukocytes in Blood
313
1868
2.71
26.60
12.4
5.4
%
0.7
0.7
0.63
305
1748
(3019198) Lymphocytes [#/volume] in Blood
341
2139
2.74
25.96
12.4
5.3
e9/l
1.9
2.0
0.34
322
1909
(3019069) Monocytes/100 leukocytes in Blood
319
1946
2.66
25.53
13.0
5.6
%
8.4
8.4
0.22
311
1835
(3006504) Eosinophils/100 leukocytes in Blood
316
1934
2.63
24.88
12.6
5.3
%
2.8
2.8
0.09
308
1808
(3002030) Lymphocytes/100 leukocytes in Blood
323
2012
2.61
24.28
12.6
5.4
%
28.6
28.6
0.02
313
1891
(3018010) Neutrophils/100 leukocytes in Blood
319
1990
2.57
23.67
12.1
5.1
%
57.4
56.8
0.45
311
1879
(3013650) Neutrophils [#/volume] in Blood by Automated count
357
2420
2.53
21.06
13.8
8.2
e9/l
4.1
4.0
0.28
331
2120
(40768443) Skin Pathology biopsy report
57
151
4.12
19.59
1.4
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
414
3148
2.57
16.86
5.8
3.7
mm/h
12.1
10.7
1.25
390
2906
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
414
3166
2.53
16.33
10.1
6.9
u/l
77.8
76.9
0.14
393
2972
(3021589) Normoblasts [#/volume] in Blood
281
1842
2.15
16.13
14.3
8.4
e9/l
0.0
0.0
0.58
256
1499
(3025159) Blasts/100 leukocytes in Blood
75
282
2.94
14.89
6.0
4.5
%
0.1
0.1
0.03
23
73
(3037522) Nuclear Ab [Titer] in Serum
125
611
2.38
14.60
1.2
1.3
titre
376.0
463.7
0.40
20
123
(3021440) Promyelocytes/100 leukocytes in Blood
76
297
2.83
14.03
6.0
4.4
%
0.1
0.2
0.21
24
84
(3017181) Myelocytes/100 leukocytes in Blood
77
318
2.67
12.75
5.9
4.3
%
1.0
1.0
0.06
25
96
(3002179) Metamyelocytes/100 leukocytes in Blood
71
288
2.70
12.16
5.5
4.2
%
0.9
0.5
0.41
19
69
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
165
970
2.03
11.83
1.7
1.6
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
15
21
7.33
10.18
2.6
1.5
%
20.5
35.9
—
10
16
(3037467) Urinalysis macro (dipstick) panel - Urine
361
2882
1.83
9.01
5.2
3.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
88
453
2.14
8.77
1.8
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
162
1030
1.83
8.76
10.1
6.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
236
1680
1.74
8.65
2.6
2.2
nmol/l
75.5
75.4
0.01
216
1524
(3021879) Hepatitis B virus core Ab [Presence] in Serum
72
364
2.14
7.48
1.4
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
164
1096
1.73
7.26
4.9
4.0
mg/mmol
21.8
10.1
0.67
118
684
(3018095) Leukocytes [#/volume] in Urine
202
1433
1.67
7.14
4.4
3.3
e6/l
26.9
55.5
1.70
147
990
(3030905) Polymorphonuclear cells [#/volume] in Blood
25
76
3.41
7.05
4.7
3.6
e9/l
3.9
4.3
0.47
25
76
(40760892) CBC W Ordered Manual Differential panel - Blood
155
1033
1.71
6.88
8.1
4.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
25
78
3.32
6.78
4.8
4.2
%
57.5
57.7
0.02
25
78
(3002582) Erythrocytes [#/volume] in Urine
173
1193
1.68
6.74
3.8
2.8
e6/l
90.2
108.4
0.09
137
915
(3017143) Hepatitis C virus Ab [Presence] in Serum
97
571
1.86
6.52
1.6
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
198
1423
1.63
6.52
3.2
3.0
u/l
33.7
32.1
0.25
188
1357
(3000494) Fungus identified in Specimen by Culture
88
503
1.90
6.48
1.4
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
151
1022
1.67
6.24
2.8
2.4
umol/l
336.7
6404.3
3.93
134
908
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
477
4335
2.27
6.16
18.6
12.0
mg/l
17.7
21.4
2.04
395
3343
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
194
1405
1.61
6.10
4.1
2.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
245
1875
1.58
6.10
6.2
6.3
mmol/l
1.2
1.2
0.29
205
1577
(3030467) Casts [#/volume] in Urine by Automated count
156
1074
1.65
6.00
3.8
2.7
e6/l
0.3
0.4
0.47
117
794
(3032080) INR in Blood by Coagulation assay
200
1470
1.59
5.86
7.9
6.9
inr
1.2
1.2
0.17
63
460
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
268
2109
1.56
5.81
5.7
5.9
umol/l
10.3
11.3
0.85
253
2000
(3026782) Osmolality of Urine
120
781
1.70
5.69
3.4
2.5
mosm/kgh2o
536.8
560.4
0.56
108
665
(3008898) HLA-B27 [Presence]
44
205
2.25
5.59
1.1
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
166
1181
1.60
5.52
4.0
3.1
mmol/l
7.4
7.9
0.71
142
999
(3012516) Albumin [Mass/volume] in Urine
150
1047
1.61
5.38
3.9
3.3
mg/l
77.2
380.4
1.44
115
676
(3000850) Epithelial cells [#/volume] in Urine
124
829
1.65
5.27
3.5
2.3
e6/l
5.5
6.4
0.21
114
728
(3021788) Differential panel - Synovial fluid
18
54
3.42
5.21
1.9
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
67
379
1.88
5.07
2.7
2.8
%
1.7
1.8
0.44
61
344
(3013826) Glucose [Moles/volume] in Serum or Plasma
285
2324
1.50
4.92
4.8
4.5
mmol/l
6.6
6.6
0.01
265
2138
(3023368) Bacteria identified in Blood by Culture
135
938
1.59
4.88
4.6
4.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
116
778
1.63
4.84
1.4
1.3
iu/ml
20.4
32.8
0.78
26
250
(3024561) Albumin [Mass/volume] in Serum or Plasma
212
1633
1.50
4.79
5.3
4.5
g/l
35.8
36.3
0.77
198
1542
(3052851) Hemolysis interference index of Serum or Plasma
27
108
2.58
4.79
2.0
2.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
90
571
1.70
4.64
1.8
1.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
72
429
1.79
4.62
6.6
6.7
mmol/l
103.6
104.1
0.35
72
418
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
61
348
1.85
4.50
1.9
2.2
g/l
0.2
0.2
0.30
53
326
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
15
44
3.48
4.50
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
26
565
0.43
4.41
1.5
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
25
101
2.55
4.36
2.2
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
99
658
1.62
4.25
1.9
1.7
nmol/l
1003.9
1201.9
1.45
79
509
(36304419) Bacteria [Presence] in Urine
146
1063
1.52
4.22
3.7
2.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
215
1694
1.46
4.20
5.5
5.6
mmol/l
1.2
1.2
0.58
194
1536
(3009871) Measles virus Ab [Titer] in Serum
9
13
7.02
4.18
1.6
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
94
622
1.62
4.11
2.4
1.8
%
1.6
1.4
1.61
81
559
(3009261) Glucose [Presence] in Urine by Test strip
258
2113
1.44
4.06
4.3
3.3
estimate
0.0
0.0
0.50
59
398
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
93
617
1.62
4.02
3.0
2.5
e6/l
1.1
1.0
0.12
56
337
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
442
4033
1.65
4.00
18.7
10.8
ml/min/173m2
87.7
86.0
0.88
395
3286
(3019550) Sodium [Moles/volume] in Serum or Plasma
465
4302
1.79
3.98
18.4
13.4
mmol/l
139.4
139.7
1.36
451
4190
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
118
830
1.55
3.97
1.6
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
192
1493
1.45
3.96
2.2
1.9
pmol/l
96.5
96.4
0.01
115
796
(3021601) Nitrite [Presence] in Urine by Test strip
255
2090
1.43
3.96
6.1
4.5
estimate
0.0
0.0
0.00
62
413
(3042936) Bacteria identified in Isolate by Culture
86
563
1.63
3.92
2.6
2.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
253
2074
1.43
3.91
4.3
3.3
estimate
0.0
0.0
0.00
56
407
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
23
95
2.49
3.86
1.0
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
139
1021
1.49
3.81
1.8
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
50
283
1.85
3.80
7.0
8.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
465
4318
1.75
3.71
18.5
13.5
mmol/l
4.0
4.0
0.03
449
4191
(3012095) Magnesium [Moles/volume] in Serum or Plasma
89
596
1.60
3.69
2.7
3.2
mmol/l
0.8
0.8
0.02
78
561
(3048689) Calprotectin [Mass/mass] in Stool
87
581
1.60
3.65
2.7
2.3
ug/g
174.3
112.8
1.12
67
450
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
107
751
1.54
3.62
1.4
1.3
u/ml
1.7
11.4
3.86
44
314
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
46
259
1.85
3.56
1.9
1.6
—
—
—
0
0
(3012544) pH of Venous blood
55
330
1.75
3.46
4.6
3.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
53
315
1.76
3.45
4.6
3.4
mmol/l
2.1
1.8
0.22
44
247
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
58
2.81
3.45
1.1
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
21
88
2.44
3.44
2.1
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
42
233
1.87
3.41
1.4
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
87
591
1.57
3.40
3.0
2.7
e6/l
2.8
2.7
0.05
52
315
(3004789) Transferrin [Mass/volume] in Serum or Plasma
82
550
1.58
3.38
2.6
2.2
g/l
2.5
2.4
1.01
76
504
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
130
965
1.46
3.34
2.7
2.0
mg/l
3.4
3.0
1.08
116
838
(3000475) Leukocytes [#/volume] in Synovial fluid
18
71
2.59
3.33
2.2
1.5
e6/l
6443.7
19313.8
0.87
12
51
(3044941) Cell count panel - Synovial fluid
14
48
2.97
3.32
2.1
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
30
151
2.05
3.22
2.2
1.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
18
73
2.52
3.16
3.1
2.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
45
264
1.77
3.08
2.7
3.0
e9/l
75.5
73.7
0.13
34
202
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
16
62
2.63
3.07
1.1
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
148
1143
1.41
3.04
2.1
2.0
u/l
187.9
233.1
0.24
140
1073
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
341
3022
1.38
2.95
3.9
2.9
u/l
56.4
43.5
1.76
315
2865
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
11
35
3.19
2.94
1.3
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
17
70
2.48
2.91
2.4
3.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
485
4609
1.82
2.87
18.5
9.1
u/l
29.6
26.7
1.56
475
4468
(3037121) Protein [Mass/volume] in Urine
27
138
2.01
2.80
3.3
3.3
g/l
0.3
0.3
0.03
18
59
(3022948) Iron [Moles/volume] in Serum or Plasma
84
598
1.48
2.64
2.7
2.2
umol/l
12.1
14.1
1.38
78
547
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
15
4.71
2.60
1.0
1.1
miu/ml
1317.1
1812.8
—
7
15
(3022217) INR in Platelet poor plasma by Coagulation assay
63
423
1.56
2.60
14.9
19.1
inr
1.2
1.3
—
10
62
(3041354) Potassium [Moles/volume] in Venous blood
13
50
2.64
2.55
3.2
2.7
mmol/l
4.3
4.0
0.78
13
50
(3035285) Chloride [Moles/volume] in Venous blood
13
50
2.64
2.55
3.2
2.7
mmol/l
104.5
105.4
0.24
13
50
(3021960) Folate [Moles/volume] in Serum or Plasma
115
876
1.40
2.52
1.6
1.5
nmol/l
19.8
21.1
0.48
107
765
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
157
1263
1.35
2.46
3.3
2.4
u/l
52.7
54.9
0.48
143
1180
(3005719) IgG [Mass/volume] in Serum or Plasma
51
332
1.59
2.41
1.2
2.4
g/l
10.4
10.4
0.01
46
301
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
64
2.38
2.41
1.8
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
56
376
1.55
2.33
5.2
3.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
502
4855
2.10
2.31
29.5
17.7
e9/l
257.4
253.7
0.63
492
4759
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
85
2.16
2.31
1.7
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
72
2.26
2.30
1.1
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
47
2.59
2.28
1.2
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
57
386
1.54
2.28
1.7
2.0
nmol/l
348.6
372.7
0.42
49
357
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
94
705
1.41
2.25
3.5
3.6
ng/l
416.2
375.9
0.05
64
494
(3024731) MCV [Entitic volume]
502
4859
2.07
2.24
29.6
17.6
fl
91.5
90.5
4.16
497
4808
(3026361) Erythrocytes [#/volume] in Blood
502
4860
2.07
2.22
29.7
17.6
e12/l
4.5
4.5
1.49
491
4754
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
71
507
1.46
2.21
2.8
2.3
%
20.6
24.3
1.17
60
440
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
18
87
2.11
2.19
1.7
1.8
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
502
4862
2.05
2.18
29.9
17.7
g/l
135.5
136.4
0.68
497
4808
(3028707) Methadone [Presence] in Urine by Screen method
20
101
2.02
2.18
2.5
2.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
37
228
1.67
2.18
3.8
3.2
kpa
5.2
5.1
0.47
32
218
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
137
1.87
2.17
1.3
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
502
4863
2.05
2.17
29.8
17.7
e9/l
6.9
6.6
1.93
491
4751
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
90
675
1.40
2.16
2.1
1.9
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
45
293
1.59
2.14
3.8
3.7
mmol/l
1.2
1.2
0.62
40
252
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
138
1.85
2.13
1.3
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
57
393
1.51
2.11
5.8
8.5
kpa
5.1
5.1
0.12
51
376
(3027801) Oxygen [Partial pressure] in Arterial blood
57
393
1.51
2.11
5.8
8.5
kpa
12.8
12.4
0.13
51
378
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
98
750
1.38
2.08
2.1
2.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
344
3127
1.30
2.08
3.4
3.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
20
103
1.98
2.08
5.2
3.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
140
1.83
2.04
1.4
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
12
50
2.43
2.04
3.3
2.7
—
—
—
0
0
(3009343) pH of Capillary blood
36
225
1.64
2.02
3.8
3.2
ph
7.4
7.4
—
5
26
(3026008) Bacteria identified in Urine by Culture
139
1127
1.32
2.02
3.4
2.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
63
2.26
2.02
1.3
1.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
77
2.11
1.98
1.1
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
142
1.80
1.96
2.1
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
132
1070
1.31
1.92
1.9
1.6
mmol/l
1.4
1.4
0.02
120
924
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
120
960
1.33
1.91
1.5
1.7
mg/l
1.2
1.0
0.20
93
723
(3003396) Base excess in Arterial blood by calculation
56
394
1.47
1.90
5.9
8.6
mmol/l
0.7
1.1
0.21
41
311
(3029937) Albumin [Presence] in Urine by Test strip
137
1118
1.31
1.90
4.7
3.5
estimate
0.0
0.0
0.50
60
404
(3044640) Blood type and Crossmatch panel - Blood
155
1288
1.29
1.87
2.4
2.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
59
2.23
1.85
1.1
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
40
2.53
1.84
5.6
4.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
120
966
1.32
1.83
2.3
2.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
359
3307
1.28
1.82
4.0
3.9
pmol/l
14.6
14.6
0.02
324
3037
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
35
2.60
1.81
1.4
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
34
217
1.61
1.78
3.5
3.3
mmol/l
1.6
1.7
0.01
26
162
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
53
374
1.46
1.78
3.5
2.3
u/l
26.1
162.6
0.53
47
311
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
18
95
1.93
1.77
2.7
2.3
ug/min
292.2
120.9
0.29
11
55
(3012501) Base excess in Blood by calculation
15
74
2.06
1.76
4.1
2.6
mmol/l
3.1
2.8
—
9
46
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
174
1477
1.27
1.76
4.1
3.3
ng/l
85.1
37.8
0.45
111
912
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
35
226
1.59
1.76
1.5
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
16
293
0.53
1.74
1.7
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
420
3958
1.32
1.72
4.9
4.6
mu/l
1.8
2.1
0.49
385
3679
(3041096) Erythrocytes [Presence] in Urine by Automated
145
1207
1.28
1.71
4.3
2.9
—
—
—
0
0
(3013512) EKG study
132
1087
1.29
1.70
4.1
3.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
10
213
0.46
1.69
5.1
1.8
mg/l
1.4
3.6
—
5
153
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
190
1636
1.25
1.69
4.8
3.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
146
0.40
1.67
1.7
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
223
1958
1.24
1.67
3.4
2.8
ug/l
99.9
108.6
0.32
211
1834
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
27
166
1.66
1.65
1.2
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
143
1.71
1.64
1.4
1.9
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
42
289
1.49
1.61
4.2
2.5
e9/l
4.6
3.9
1.14
35
246
(3014133) Dog dander IgE Ab [Units/volume] in Serum
13
63
2.09
1.61
1.1
1.0
u/ml
1.8
1.4
—
5
17
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
26
2.71
1.58
1.3
1.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
20
3.02
1.58
1.8
3.6
nmol/l
73.2
91.3
—
6
20
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
222
1957
1.24
1.58
4.1
4.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
432
4101
1.32
1.58
4.5
4.0
mmol/l
6.0
5.8
1.13
393
3802
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
100
802
1.31
1.57
1.8
1.6
pmol/l
424.5
433.8
0.18
88
695
(3019225) pH of Specimen
49
350
1.44
1.56
3.9
3.9
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
141
0.42
1.54
1.7
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
142
0.42
1.54
1.7
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
51
369
1.42
1.53
4.4
3.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
15
3.35
1.52
4.2
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
15
3.35
1.52
1.4
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
27
2.61
1.52
1.1
1.1
iu/ml
325.0
143.2
—
7
27
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
21
2.88
1.51
6.3
3.0
u/ml
418.0
546.2
—
6
21
(3026389) Candida sp identified in Specimen by Organism specific culture
9
37
2.46
1.48
1.2
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
113
928
1.28
1.48
4.1
3.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
38
2.39
1.46
1.7
1.9
pg
30.9
33.5
—
9
38
(3035320) C reactive protein [Mass/volume] in Body fluid
6
22
2.75
1.44
3.5
2.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
53
392
1.39
1.41
1.7
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
40
2.27
1.40
1.1
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
40
2.27
1.40
1.1
2.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
40
2.27
1.40
1.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
40
2.27
1.40
1.1
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
40
2.27
1.40
1.3
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
116
964
1.26
1.38
3.2
3.1
ng/l
1826.1
1190.3
0.32
100
818
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
90
1.80
1.34
1.1
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
83
1.83
1.32
1.5
2.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
29
193
1.53
1.32
1.5
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
60
460
1.34
1.30
2.5
2.5
umol/l
6.7
8.7
0.62
51
395
(3045424) Erythrocytes [Presence] in Urine
13
69
1.91
1.29
1.1
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
18
2.79
1.29
1.0
1.6
nmol/l
130.8
143.4
—
5
18
(3004451) EKG impression Narrative
5
18
2.79
1.29
1.2
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
151
1304
1.22
1.27
2.5
3.0
mmol/l
2.3
2.4
1.12
130
1167
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
115
1.68
1.26
1.4
2.0
iu/l
1.9
6.3
—
7
44
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
14
240
0.57
1.26
2.5
2.5
u/ml
14.4
43.0
1.94
14
231
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
25
2.42
1.24
1.2
1.2
—
—
—
0
0
(4198724)
6
25
2.42
1.24
4.8
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
5
19
2.65
1.22
1.4
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
51
387
1.35
1.19
1.7
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
26
2.32
1.19
1.3
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
35
249
1.44
1.18
2.6
3.0
ng/l
174.9
175.4
0.00
29
220
(3022145) Colonoscopy Study observation
62
486
1.31
1.17
1.7
1.3
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
0
35
0.00
1.15
0.0
1.5
—
20.6
—
0
30
(3004716) Salmonella sp identified in Stool by Organism specific culture
37
268
1.41
1.14
1.3
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
24
159
1.53
1.14
1.3
1.2
—
—
—
0
0
(3020891) Body temperature
22
143
1.56
1.13
6.0
4.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
10
51
1.98
1.12
1.1
1.1
u/ml
1.3
4.5
—
5
16
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
96
1.69
1.11
1.6
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
42
313
1.37
1.10
4.5
3.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
403
3842
1.22
1.10
6.8
5.1
mmol/mol
39.9
39.2
0.70
376
3621
(44790049)
8
41
1.97
1.09
2.3
1.7
—
—
—
0
0
(44806118)
8
41
1.97
1.09
2.3
1.7
—
—
—
0
0
(44790048)
8
41
1.97
1.09
2.3
1.7
—
—
—
0
0
(44790047)
8
41
1.97
1.09
2.3
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
13
74
1.78
1.07
1.1
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
33
2.14
1.06
1.1
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
18
114
1.60
1.04
1.0
1.3
—
2.6
—
0
14
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
22
2.28
1.03
1.2
1.4
mmol/l
5.5
6.5
—
5
22
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
47
1.93
1.02
1.1
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
48
1.89
1.01
1.4
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
468
4548
1.30
0.99
17.4
11.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
440
4246
1.24
0.98
5.3
4.0
mmol/l
4.7
4.7
0.15
408
4001
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
23
2.19
0.98
1.6
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
92
1.65
0.98
1.3
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
130
1134
1.20
0.98
4.3
3.6
ph
7.4
7.4
0.36
23
208
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
18
116
1.57
0.98
1.0
1.3
—
7.3
—
0
20
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
36
1.96
0.97
2.3
2.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
62
1.79
0.95
1.5
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
27
192
1.43
0.94
5.1
3.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
70
1.73
0.93
2.8
2.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
52
1.74
0.92
2.4
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
22
151
1.48
0.92
1.5
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
52
646
0.78
0.91
2.7
2.8
ug/l
0.6
0.7
0.29
34
393
(40768797) Stomach Pathology biopsy report
67
551
1.25
0.90
1.3
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
42
1.92
0.89
1.3
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
79
1.66
0.88
1.2
1.1
u/ml
0.3
1.7
—
5
28
(3022806) Fractional oxyhemoglobin in Capillary blood
8
43
1.87
0.87
2.3
1.8
%
84.7
89.9
—
8
43
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
39
300
1.32
0.87
2.5
2.3
ug/l
7.2
8.0
0.18
31
270
(3043409) Potassium [Moles/volume] in Arterial blood
17
112
1.54
0.86
4.9
3.9
mmol/l
4.0
3.9
0.50
17
104
(3015171) Extractable nuclear Ab [Units/volume] in Serum
25
179
1.42
0.85
1.1
1.2
—
2.5
—
0
11
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
31
1.95
0.84
1.7
3.2
—
—
—
0
0
(3000492) Spirometry study
56
457
1.25
0.81
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
11
176
0.62
0.81
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
11
176
0.62
0.81
1.5
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
30
225
1.35
0.80
3.1
2.2
u/l
5593.8
3142.0
—
10
105
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
175
0.62
0.79
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
11
175
0.62
0.79
1.5
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
33
1.83
0.79
1.8
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
23
165
1.41
0.79
4.5
3.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
90
1.57
0.79
1.2
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
123
1.48
0.78
1.2
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
24
174
1.40
0.78
1.7
1.7
—
—
—
0
0
(1002224) Polysomnography panel
16
233
0.68
0.78
1.1
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
106
928
1.18
0.77
4.5
3.5
kg/l
1.0
1.0
0.01
23
125
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
18
124
1.47
0.76
1.0
1.3
—
2.3
—
0
6
(3004588) Protein electrophoresis panel - Serum or Plasma
32
245
1.33
0.76
1.5
2.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
13
83
1.58
0.75
1.2
3.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
196
0.65
0.75
2.5
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.0
1.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
24
2.09
0.74
2.0
1.8
%
9.1
11.3
—
5
24
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.0
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.0
1.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.0
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
422
4085
1.18
0.74
4.8
3.6
mmol/l
1.4
1.3
1.07
390
3828
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
55
1.65
0.74
1.4
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
20
142
1.42
0.73
1.8
1.8
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
25
2.01
0.73
2.2
1.9
—
1224630.0
—
0
5
(44813793)
5
25
2.01
0.73
1.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
39
1.81
0.72
1.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
56
1.62
0.72
1.4
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
56
1.62
0.72
1.4
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
24
177
1.37
0.72
2.5
1.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
118
1049
1.16
0.72
1.3
1.2
u/ml
0.8
2.0
1.49
29
302
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
61
1.65
0.69
2.3
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
43
1.64
0.67
1.0
1.0
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
86
1.52
0.66
1.0
1.3
—
1.0
—
0
5
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
28
1.79
0.66
1.4
1.3
mmol/l
3.4
1.9
—
5
28
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
28
1.79
0.66
1.0
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
299
2840
1.12
0.65
3.4
3.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
183
1689
1.13
0.64
2.0
2.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
5
30
1.67
0.61
16.8
9.3
mmol/l
0.4
0.6
—
5
30
(36660697) Celiac disease serology panel - Serum
43
355
1.23
0.60
1.2
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
89
1.47
0.58
1.0
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
117
1288
0.88
0.56
1.7
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
55
1.46
0.56
1.5
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
37
1.63
0.55
3.0
3.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
14
99
1.43
0.54
2.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
74
1.50
0.53
1.3
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
74
1.50
0.53
1.3
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
74
1.50
0.53
1.8
2.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
105
947
1.14
0.53
1.3
1.4
g/l
2.7
2.4
0.73
61
616
(3013139) Helicobacter pylori Ag [Presence] in Stool
34
278
1.24
0.53
1.3
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
63
1.44
0.52
1.7
2.7
—
1032.0
—
0
6
(3050129) First trimester maternal screen panel - Serum or Plasma
16
214
0.74
0.52
1.5
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
40
1.51
0.51
1.2
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
40
1.51
0.51
2.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
40
1.51
0.51
1.2
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
10
145
0.68
0.51
1.0
1.1
—
6.3
—
0
21
(3019060) Gas panel - Arterial blood
28
225
1.26
0.50
4.1
6.5
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
41
1.47
0.50
1.5
2.9
u/ml
22.7
51.3
—
6
41
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
17
128
1.34
0.48
1.3
1.9
%
100.4
90.3
1.14
17
122
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
188
0.74
0.47
1.5
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
83
0.60
0.46
3.2
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
32
266
1.22
0.44
3.3
2.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
32
267
1.21
0.43
5.2
3.6
ng/l
131.9
76.1
1.13
27
242
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
42
360
1.18
0.43
4.1
4.3
ug/l
3.2
19.0
0.73
32
294
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
31
1.62
0.43
1.2
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
26
212
1.24
0.43
2.3
2.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
56
1.44
0.42
1.5
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
56
1.44
0.42
1.5
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
32
1.57
0.42
1.8
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
32
1.57
0.42
1.2
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
10
70
1.44
0.42
1.1
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
440
4318
1.13
0.41
5.3
4.4
mmol/l
2.8
2.8
0.12
408
4040
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
5
33
1.52
0.41
1.4
1.2
u/ml
—
0.1
—
0
14
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
15
0.00
0.41
0.0
3.3
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
15
0.00
0.41
0.0
6.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
37
315
1.19
0.41
3.8
2.6
ml/min/173m2
64.6
69.2
0.44
21
135
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
19
150
1.28
0.40
2.8
2.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
53
466
1.15
0.40
4.5
4.1
%
30.5
31.6
0.33
34
323
(3051611) Lipemic interference index of Serum or Plasma
5
34
1.48
0.40
2.6
2.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
34
1.48
0.40
1.2
2.0
—
—
—
0
0
(3035880) pH of Pleural fluid
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
71
1.42
0.39
2.3
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.6
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
160
1698
0.92
0.39
3.1
2.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
160
1.26
0.39
1.9
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
80
878
0.89
0.38
3.8
4.1
%
25.3
20.7
0.92
31
378
(3025130) Human papilloma virus identified in Specimen
9
68
1.33
0.37
1.8
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
5
37
1.35
0.37
1.6
1.5
g/l
35.3
32.2
—
5
32
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
71
1.27
0.36
1.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
90
1.34
0.36
1.6
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
78
0.64
0.36
1.0
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
14
108
1.30
0.35
1.4
3.3
—
2.1
—
0
16
(4034850)
10
134
0.74
0.35
2.7
7.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
43
1.40
0.35
1.0
2.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
45
1.34
0.34
1.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
14
109
1.29
0.34
1.4
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
51
455
1.13
0.33
14.0
5.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
46
1.31
0.33
1.0
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
46
1.31
0.33
1.5
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
430
4228
1.10
0.33
4.9
4.0
mmol/l
1.4
1.5
0.43
400
3971
(3009445) Proteinase 3 Ab [Units/volume] in Serum
21
174
1.22
0.32
1.1
1.4
—
11.1
—
0
5
(3000764) Benzodiazepines [Presence] in Urine
27
230
1.18
0.31
2.4
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
29
249
1.17
0.31
1.1
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
53
1.33
0.31
2.7
2.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
21
175
1.21
0.30
1.3
1.4
miu/ml
214.4
251.2
—
10
88
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
75
1.34
0.30
1.4
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
55
1.28
0.30
1.6
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
27
232
1.17
0.29
2.4
1.9
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
28
242
1.17
0.28
1.3
1.3
iu/l
35.0
25.9
0.52
22
205
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
8
62
1.29
0.28
2.9
2.5
u/ml
9.1
70.8
—
8
57
(3028300) Cannabinoids [Presence] in Urine
27
233
1.17
0.28
2.4
1.9
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
9
116
0.77
0.27
1.4
1.8
g/l
39.3
37.9
—
9
105
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
8
64
1.25
0.27
1.1
1.1
%
131.0
116.9
—
8
59
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
95
1.27
0.26
2.5
3.1
u/ml
0.3
0.4
—
7
54
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
138
0.79
0.26
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
56
513
1.10
0.25
1.1
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
74
1.22
0.25
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
31
349
0.88
0.24
1.1
1.2
iu/ml
92.3
169.1
1.37
13
145
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
46
419
1.11
0.23
2.5
1.9
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
5
38
1.32
0.23
8.6
7.0
mmol/l
6.6
6.4
—
5
28
(3005570) Glucose [Moles/volume] in Urine
5
38
1.32
0.23
1.2
2.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
146
0.82
0.22
1.7
1.6
—
—
—
0
0
(4062490)
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
11
0.00
0.21
0.0
1.5
—
9.6
—
0
6
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.2
—
2.4
—
0
6
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
126
1.20
0.21
1.3
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.5
—
0
7
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
14
0.00
0.20
0.0
3.9
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
14
0.00
0.20
0.0
3.9
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
14
0.00
0.20
0.0
3.9
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
26
231
1.13
0.20
2.4
1.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
81
1.24
0.19
1.5
1.8
—
—
—
0
0
(4268621)
6
53
1.13
0.18
1.8
2.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
59
1.19
0.18
1.9
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
16
138
1.16
0.17
1.3
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
29
319
0.90
0.17
1.6
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
69
1.16
0.16
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
92
1.20
0.16
1.5
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
78
0.77
0.15
1.5
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
30
327
0.91
0.15
1.6
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
50
532
0.93
0.15
1.6
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
15
132
1.14
0.13
1.6
1.8
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
13
113
1.15
0.13
1.5
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
72
688
1.05
0.13
2.8
2.7
mmol/l
2.4
2.4
0.04
65
609
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
9
106
0.85
0.13
1.4
1.9
g/l
0.0
0.0
—
9
101
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
18
161
1.12
0.13
2.6
1.7
—
—
—
0
0
(4010399)
27
293
0.92
0.12
1.2
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
35
330
1.06
0.09
2.3
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
116
1.12
0.09
2.0
2.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
45
471
0.95
0.09
1.7
1.6
—
—
—
0
0
(4306422)
7
66
1.06
0.08
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
12
133
0.90
0.07
4.4
2.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
70
0.86
0.07
1.2
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
20
186
1.08
0.07
1.3
1.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
10
112
0.89
0.07
1.4
1.9
g/l
0.1
0.0
—
10
107
(3044290) Cell count panel - Cerebral spinal fluid
9
88
1.02
0.07
1.1
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
107
1092
0.97
0.06
4.4
4.4
ug/l
1.4
2.1
1.53
93
980
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
182
0.93
0.05
6.2
11.4
—
—
—
0
0
(4035726)
31
323
0.96
0.05
1.4
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
81
795
1.02
0.04
1.5
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
54
553
0.97
0.04
1.4
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
382
3834
0.99
0.03
25.6
15.0
g/l
332.2
333.0
1.04
377
3815
(3009542) Hematocrit [Volume Fraction] of Blood
407
4081
0.99
0.02
20.6
12.4
%
39.2
40.5
1.66
299
3183
(3019832) Treponema pallidum Ab [Presence] in Serum
61
601
1.02
0.02
1.6
1.7
—
—
—
0
0
(4094501)
11
116
0.95
0.00
1.1
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
17
164
1.04
0.00
1.4
1.4
g/l
1.3
1.2
0.71
17
157
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
20
196
1.02
0.00
2.0
2.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
143
0.98
0.00
1.3
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
143
0.98
0.00
1.3
1.9
g/l
3.9
3.9
—
9
108
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
102
0.98
0.00
1.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
59
0.85
0.00
19.2
1.9
%
13.2
13.2
—
5
59
(40757373) Influenza virus identified in Isolate
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
6.6
—
0
8
(3034988) Calcium [Moles/volume] in Capillary blood
0
8
0.00
0.00
0.0
1.1
—
1.2
—
0
8
(3003740) Influenza virus B Ag [Presence] in Specimen
9
95
0.95
0.00
1.0
1.1
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
116.1
—
0
7
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
8.2
—
0
7
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(4015189)
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
7
0.00
0.00
0.0
1.1
—
1.3
—
0
7
(44806420)
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
16.7
—
0
5
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
9
0.00
0.00
0.0
10.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
60
1.00
0.00
1.2
1.7
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
3.0
—
6.4
—
0
5
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
18.6
—
0
5
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
1.9
—
0
9
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
95
0.95
0.00
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
52
0.96
0.00
1.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
9
0.00
0.00
0.0
10.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
87
0.92
0.00
2.6
1.9
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
12.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.6
—
48.9
—
0
7
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
50
1.00
-0.00
1.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_PSORI_GUTTATE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_PSORI_GUTTATE | 1.255 [1.02, 1.54] | 0.032 |
| Birth year | 0.994 [0.99, 1.0] | 0.2 |
During the follow-up period (1.1.1998 — 31.12.2019), 164 out of 1925 females with L12_PSORI_GUTTATE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_PSORI_GUTTATE | 1.695 [1.38, 2.08] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 209 out of 1420 males with L12_PSORI_GUTTATE died.
Mortality risk
Mortality risk for people of age
years, who have L12_PSORI_GUTTATE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.107% | 0.352% |
| 5 | 0.745% | 1.989% |
| 10 | 1.799% | 4.954% |
| 15 | 3.345% | 9.073% |
| 20 | 5.875% | 14.936% |
Relationships between endpoints
↥Index endpoint: L12_PSORI_GUTTATE – Guttate psoriasis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data